Barclays’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,688
| Closed | -$23K | – | 4599 |
|
|
2025
Q1 | $23K | Sell |
12,688
-51,361
| -80% | -$93.1K | ﹤0.01% | 4047 |
|
|
2024
Q4 | $109K | Buy |
64,049
+19,436
| +44% | +$33.1K | ﹤0.01% | 3774 |
|
|
2024
Q3 | $152K | Sell |
44,613
-142
| -0.3% | -$484 | ﹤0.01% | 3612 |
|
|
2024
Q2 | $179K | Sell |
44,755
-68,281
| -60% | -$273K | ﹤0.01% | 3102 |
|
|
2024
Q1 | $386K | Sell |
113,036
-10,759
| -9% | -$36.7K | ﹤0.01% | 2985 |
|
|
2023
Q4 | $419K | Buy |
123,795
+19,205
| +18% | +$65K | ﹤0.01% | 3105 |
|
|
2023
Q3 | $564K | Sell |
104,590
-312
| -0.3% | -$1.68K | ﹤0.01% | 2470 |
|
|
2023
Q2 | $986K | Buy |
104,902
+654
| +0.6% | +$6.15K | ﹤0.01% | 2166 |
|
|
2023
Q1 | $1.02M | Sell |
104,248
-1,645
| -2% | -$16.1K | ﹤0.01% | 2125 |
|
|
2022
Q4 | $1.32M | Buy |
105,893
+3,730
| +4% | +$46.6K | ﹤0.01% | 1919 |
|
|
2022
Q3 | $929K | Buy |
102,163
+482
| +0.5% | +$4.38K | ﹤0.01% | 2192 |
|
|
2022
Q2 | $262K | Sell |
101,681
-1,092
| -1% | -$2.81K | ﹤0.01% | 2996 |
|
|
2022
Q1 | $722K | Buy |
+102,773
| New | +$722K | ﹤0.01% | 2547 |
|